LivaNova LIVN Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Business | ||||||
| Cardiopulmonary | $817.72M+4.1% | $785.39M+3.3% | $760.48M+4.2% | $729.5M+3.6% | $703.94M+3.0% | |
| Neuromodulation | $605.71M+2.2% | $592.81M+2.6% | $577.7M+1.7% | $568.04M+1.6% | $559.24M+0.9% | |
| Net revenue by Geography | ||||||
| Europe | $285.13M+5.9% | $269.18M+5.2% | $255.78M+6.2% | $240.91M+6.9% | $225.39M+2.4% | |
| Rest of World | $393.24M+3.7% | $379.3M+2.5% | $370M+4.0% | $355.86M+2.7% | $346.36M+2.4% | |
| United States | $755.09M+2.1% | $739.57M+2.3% | $723.18M+1.5% | $712.56M+1.3% | $703.63M+1.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does LivaNova break its business down?
- LivaNova (LIVN) reports net revenue by business across 2 parts — Cardiopulmonary and Neuromodulation. Each is extracted from the segment footnotes and tracked over time.
- Where does LivaNova's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in LivaNova's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.